Amryt Pharma (Amryt Pharma) Total Stockholders Equity : $324.3 Mil (As of Sep. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Amryt Pharma Total Stockholders Equity?

Amryt Pharma's Total Stockholders Equity for the quarter that ended in Sep. 2022 was $324.3 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Amryt Pharma's Book Value per Share for the quarter that ended in Sep. 2022 was $5.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Amryt Pharma's Debt-to-Equity for the quarter that ended in Sep. 2022 was 0.66.

Amryt Pharma Total Stockholders Equity Historical Data

The historical data trend for Amryt Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amryt Pharma Total Stockholders Equity Chart

Amryt Pharma Annual Data

Trend

Mar12

Mar13

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Stockholders Equity

Get a 7-Day Free Trial

26.26

-3.70

131.83

66.14

356.66

Amryt Pharma Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Stockholders Equity	Get a 7-Day Free Trial															306.02	356.66	345.98	342.03	324.28

Amryt Pharma (NAS:AMYT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Amryt Pharma's Book Value per Share for the quarter that ended in Sep. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(324.277	-	0)	/	63.9717
	=	5.07

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Amryt Pharma's Debt-to-Equity for the quarter that ended in Sep. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.966	+	211.825)	/	324.277
	=	0.66

Amryt Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Amryt Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Amryt Pharma (Amryt Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amryt Pharma PLC (NAS:AMYT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

196 High Road, Dept 920A, Wood Green, London, GBR, N22 8HH

Website

http://www.amrytpharma.com

Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).